NFKB1 and cancer: Gui et al. demonstrated that IL-1β can trigger HIF-1 through NF-κB/COX-2 signaling pathway, suggesting that HIF-1 is a bridge linking inflammation and tumor and IL-1β possesses a cancer promoting property [21].